Free CE/CME Activities
Browse free continuing education activities across medical specialties
Clinical Crossroads™: The Importance of Considering Lambert-Eaton Myasthenic Syndrome (LEMS) in the Differential Diagnosis
Available through July 1, 2027
Katherine Ruzhansky, MD, MS; Perry Shieh, MD, PhD, FAAN
From Chair to Care Plan—Applying Evidence to Patient-Centered Management
Available through July 1, 2027
Walter Whitley, OD, MBA, FAAO; Cecelia Koetting, OD, FAAO, DipABO
Timing Is Everything—Onset, Duration, and Dosing in Real-World Care
Available through July 1, 2027
Walter Whitley, OD, MBA, FAAO; Cecelia Koetting, OD, FAAO, DipABO
From Dropout to Long-Term Wear—A Case-Based Approach to Personalized Contact Lens Care
Available through July 1, 2027
Adam Ramsey, OD; Jessilin Quint, OD, MBA, MS, FAAO
Expanding the Fit—Mastering Toric and Multifocal Success in Complex Patients
Available through July 1, 2027
Adam Ramsey, OD; Jessilin Quint, OD, MBA, MS, FAAO
Mechanism Matters—How OTC Therapies Interrupt the Allergic Cascade
Available through July 1, 2027
Walter Whitley, OD, MBA, FAAO; Cecelia Koetting, OD, FAAO, DipABO
Modality Matters—Optimizing Contact Lens Selection for Real-World Wear
Available through July 1, 2027
Adam Ramsey, OD; Jessilin Quint, OD, MBA, MS, FAAO
Burst CME™ Part VI: What Does this all Mean for Patients with IgAN?
Available through July 1, 2027
Professor Jonathan Barratt, PhD, FRCP; Richard Lafayette, MD
Burst CME™ Part V: Complement Inhibitors in IgAN
Available through July 1, 2027
Professor Jonathan Barratt, PhD, FRCP; Richard Lafayette, MD
Burst CME™ Part IV: Anti-CD38 Therapies in IgAN
Available through July 1, 2027
Professor Jonathan Barratt, PhD, FRCP; Richard Lafayette, MD
Burst CME™ Part III: BAFF and APRIL Directed Therapies in IgAN
Available through July 1, 2027
Professor Jonathan Barratt, PhD, FRCP; Richard Lafayette, MD
Burst CME™ Part II: Endothelin A Receptor Antagonists in IgAN
Available through July 1, 2027
Professor Jonathan Barratt, PhD, FRCP; Richard Lafayette, MD








